4-Hydrazinyl-N-methylbenzeneethanesulfonamide hydrochloride
CAS: 42381-27-1
Ref. 3D-FH23878
| 1g | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued | ||
| 250mg | Discontinued | ||
| 500mg | Discontinued |
Product Information
Name:
4-Hydrazinyl-N-methylbenzeneethanesulfonamide hydrochloride
Synonyms:
- 4-Hydrazino-N-methylbenzeneethanesulfonamide hydrochloridep-[b-(Methylsulfonamido)ethyl]phenylhydrazine hydrochloride
- 2-(4-hydrazinophenyl)-N-methylethanesulfonamide hydrochloride
- 4-Hydrazino-N-Methyl Benzene Ethane Sulfonamide Hydrochloride
- 4-Hydrazino-N-Methylbenzenethanesulfonamide Hydrochloride
- Benzeneethanesulfonamide, 4-hydrazino-N-methyl-, monohydrochloride
- Benzeneethanesulfonamide, 4-hydrazinyl-N-methyl-, hydrochloride (1:1)
- p-[beta-(Methylsulfonamido)ethyl]phenylhydrazine hydrochloride
- p-[β-(Methylsulfonamido)ethyl]phenylhydrazine hydrochloride
Description:
This drug is a beta-adrenergic blocking agent that has been shown to be useful in the treatment of high blood pressure. It is also used for the treatment of asthma, chronic obstructive pulmonary disease, and cardiac arrhythmias. The optical isomers are reported to have different pharmacological properties. This drug binds to beta-adrenergic receptors and prevents the binding of epinephrine (adrenaline) to these receptors, thereby inhibiting its effects on the heart and lungs. 4-Hydrazinyl-N-methylbenzeneethanesulfonamide hydrochloride is metabolized by carboxylic esters in the liver. Hydrolysis leads to release of 4'-hydroxymethylene-4H-1,2,4-triazolium cation, which produces an inhibitory effect on erythrocyte aggregation.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
265.76 g/mol
Formula:
C9H16ClN3O2S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
